ANI Pharmaceuticals, Inc. Board of Directors

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Mr. Nikhil Lalwani

Mr. Nikhil Lalwani

President, CEO & Director

Mr. Chad Gassert

Mr. Chad Gassert

Senior Vice President of Corporate Development & Strategy

Mr. Ori Gutwerg

Mr. Ori Gutwerg

Senior Vice President of Generics

Mr. Stephen P. Carey

Mr. Stephen P. Carey

Senior VP of Finance & CFO

Ms. Krista L. Davis

Ms. Krista L. Davis

Senior VP & Chief Human Resources Officer

Mr. Muthusamy Shanmugam MS R.Ph.

Mr. Muthusamy Shanmugam MS R.Ph.

Head of R&D, COO of Novitium Operations & Director

Ms. Elizabeth Powell J.D.

Ms. Elizabeth Powell J.D.

Chief Compliance Officer & Head of Legal of Rare Disease

Ms. Meredith W. Cook J.D.

Ms. Meredith W. Cook J.D.

Senior VP, General Counsel & Corporate Secretary

Mr. Christopher K. Mutz

Mr. Christopher K. Mutz

Senior VP & Head of Rare Disease

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.